In this podcast, Executive Director of Business Development in Europe, Nick Heaton, talks about the major drivers of growing demands in Europe for advanced drug delivery devices, and the measures taken to enhance our relationship with patients and biopharmaceutical companies. Heaton also addresses challenges faced when launching a new product and explains the main difference between preconfigured program and development program offered by SHL, as well each program’s respective opportunities and advantages.

To listen to the SHL Podcast, please click HERE